annual cash & cash equivalents:
$669.44M+$423.99M(+172.74%)Summary
- As of today (June 3, 2025), MEDP annual cash & cash equivalents is $669.44 million, with the most recent change of +$423.99 million (+172.74%) on December 31, 2024.
- During the last 3 years, MEDP annual cash & cash equivalents has risen by +$208.13 million (+45.12%).
- MEDP annual cash & cash equivalents is now at all-time high.
Performance
MEDP Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$441.44M-$228.00M(-34.06%)Summary
- As of today (June 3, 2025), MEDP quarterly cash & cash equivalents is $441.44 million, with the most recent change of -$228.00 million (-34.06%) on March 31, 2025.
- Over the past year, MEDP quarterly cash & cash equivalents has increased by +$34.43 million (+8.46%).
- MEDP quarterly cash & cash equivalents is now -34.06% below its all-time high of $669.44 million, reached on December 31, 2024.
Performance
MEDP quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MEDP Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +172.7% | +8.5% |
| 3 y3 years | +45.1% | +432.9% |
| 5 y5 years | +407.5% | +229.4% |
MEDP Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2268.4% | -34.1% | +1461.8% |
| 5 y | 5-year | at high | +2268.4% | -34.1% | +1461.8% |
| alltime | all time | at high | +4398.9% | -34.1% | +3128.3% |
MEDP Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $441.44M(-34.1%) |
| Dec 2024 | $669.44M(+172.7%) | $669.44M(+1.9%) |
| Sep 2024 | - | $656.90M(+28.6%) |
| Jun 2024 | - | $510.89M(+25.5%) |
| Mar 2024 | - | $407.01M(+65.8%) |
| Dec 2023 | $245.45M(+768.4%) | $245.45M(+157.8%) |
| Sep 2023 | - | $95.21M(+143.3%) |
| Jun 2023 | - | $39.14M(-16.6%) |
| Mar 2023 | - | $46.92M(+66.0%) |
| Dec 2022 | $28.27M(-93.9%) | $28.27M(-8.8%) |
| Sep 2022 | - | $31.01M(-27.1%) |
| Jun 2022 | - | $42.55M(-48.6%) |
| Mar 2022 | - | $82.84M(-82.0%) |
| Dec 2021 | $461.30M(+66.1%) | $461.30M(+15.8%) |
| Sep 2021 | - | $398.39M(+17.5%) |
| Jun 2021 | - | $339.01M(+1.8%) |
| Mar 2021 | - | $332.88M(+19.8%) |
| Dec 2020 | $277.77M | $277.77M(+26.7%) |
| Sep 2020 | - | $219.23M(+36.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $160.90M(+20.1%) |
| Mar 2020 | - | $134.00M(+1.6%) |
| Dec 2019 | $131.92M(+466.8%) | $131.92M(+66.4%) |
| Sep 2019 | - | $79.29M(+294.5%) |
| Jun 2019 | - | $20.10M(-33.3%) |
| Mar 2019 | - | $30.13M(+29.4%) |
| Dec 2018 | $23.27M(-12.1%) | $23.27M(+4.6%) |
| Sep 2018 | - | $22.24M(+0.1%) |
| Jun 2018 | - | $22.23M(-0.1%) |
| Mar 2018 | - | $22.25M(-16.0%) |
| Dec 2017 | $26.48M(-28.6%) | $26.48M(+9.6%) |
| Sep 2017 | - | $24.17M(-16.8%) |
| Jun 2017 | - | $29.05M(-0.9%) |
| Mar 2017 | - | $29.32M(-21.0%) |
| Dec 2016 | $37.10M(+149.3%) | $37.10M(+153.5%) |
| Sep 2016 | - | $14.64M(+7.0%) |
| Jun 2016 | - | $13.67M(-43.5%) |
| Mar 2016 | - | $24.18M(+62.5%) |
| Dec 2015 | $14.88M(-72.6%) | $14.88M |
| Dec 2014 | $54.28M | - |
FAQ
- What is Medpace Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Medpace Holdings?
- What is Medpace Holdings annual cash & cash equivalents year-on-year change?
- What is Medpace Holdings quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Medpace Holdings?
- What is Medpace Holdings quarterly cash & cash equivalents year-on-year change?
What is Medpace Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of MEDP is $669.44M
What is the all time high annual cash & cash equivalents for Medpace Holdings?
Medpace Holdings all-time high annual cash & cash equivalents is $669.44M
What is Medpace Holdings annual cash & cash equivalents year-on-year change?
Over the past year, MEDP annual cash & cash equivalents has changed by +$423.99M (+172.74%)
What is Medpace Holdings quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MEDP is $441.44M
What is the all time high quarterly cash & cash equivalents for Medpace Holdings?
Medpace Holdings all-time high quarterly cash & cash equivalents is $669.44M
What is Medpace Holdings quarterly cash & cash equivalents year-on-year change?
Over the past year, MEDP quarterly cash & cash equivalents has changed by +$34.43M (+8.46%)